Chinese Therapeutics Startup Harbour BioMed Musters US$102.8M Series C

Harbour BioMed takes its capital pool to well over US$300 million with this round

Shanghai-based biotech startup Harbour BioMed has rounded off its Series C financing with a haul of US$102.8 million, the company announced in a statement today.

Hudson Bay Capital led the round, with participation from OrbiMed, Country Garden VC, GTJA Investment Group, Octagon Capital, and Sage Partners, the statement said. Existing backer Greater Bay Area Homeland Development Fund also joined Harbour BioMed’s league of Series C investors, it added.

With this round of funding, the startup has now raised over $177 million just in the first half of 2020, the statement noted.

The startup had earlier aggregated total funding of $210 million prior to the Series C. With this capital injection, Harbour BioMed’s total funding now stands at $312.8 million, not including its 2018 Series A+ round of an undisclosed amount.

The company had earlier closed its Series B+ financing in March this year, where it raised $75 million from investors including Zhejiang University, Singapore state-owned GIC, and Greater Bay Area Homeland Development Fund.

Harbour BioMed is a clinical stage therapeutics company with operations in Massachusetts, U.S., Rotterdam, the Netherlands, and Suzhou, China, in addition to its headquarters in Shanghai. The company will be focusing its funds toward growing its portfolio of next-gen biologics that target cancer, immunologic diseases, and COVID-19, the statement noted.

Founder, Chairman and CEO of Harbour BioMed, Dr Jingsong Wang said in the statement that the company’s clinical programs were “rapidly moving” to the clinical trials stage.

“The funding will support final development and initial commercialization of our late stage portfolio and advancement of both our earlier stage discovery and preclinical molecules,” he added.

Currently, five of the company’s products are at the clinical development stage, the statement noted. These include monoclonal antibodies (mAb) HBM9161 (Batoclimab), HBM4003, HBM9036 (Tanfanercept).

While Batoclimab is currently in the clinical trial stage in China, with approval from National Medical Products Administration (NMPA) as an investigational new drug (IND), preparations are underway for Phase 3 registration trials for Tanfanercept in China, the statement said.

It added that HBM4003 has received IND approval from the Food and Drug Administration (FDA) for clinical trials in the U.S.

The company has a total of 30 programs targeted toward different types of cancer, all in the preclinical development stage. Additionally, it says it is also developing a “COVID-19 pipeline.”

Harbour BioMed recently announced a research collaboration with American biopharma AbbVie, along with Utrecht University and Erasmus Medical Centre, to study the therapeutic and prophylactic use case of mAb 47D11 targeting the SARS-CoV2 virus, or the novel coronavirus, the statement said.

Further, it added that the company is also working with New York-based Mount Sinai Health System for the discovery of antibodies targeting SARS-CoV2.

Header image by National Cancer Institute on Unsplash

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email

RELATED POSTS

Shrinkflation

What Is “Shrinkflation” and Why Opting For It Isn’t Companies’ Only Choice

You might have noticed grocery prices are soaring, or your usual go-to pack of chips is shrinking in size—all thanks to massive inflation. As of August 2022, the U.S. consumer price index (CPI), which measures the change in consumer prices for a specific set of goods over a period, has increased by 8.3% (year-on-year). Although it has gone down slightly from 8.6% in May, the highest it has ever been since 1981, it remains high and worrying.

Top 3 Affordable and Little-Known Smartphones to Bring Home in 2022

Top 3 Affordable and Little-Known Smartphones to Bring Home in 2022

Apple has remained at the center of the smartphone industry for years. The sleek, striking design, ever-improving chip and robust camera system of the iPhone have made it one of the most sought-after smartphones in the world. This month, Apple cemented and extended its lead in the industry by putting forward the next generation of iPhones.

5 More Business Podcasts You Need to Listen To

5 More Business Podcasts You Need to Listen To

Entrepreneurs have one thing in common—they always look for opportunities to learn and grow. To gain an understanding of running a viable business, you need to listen to the experiences of those who have emerged triumphant in the business world. A great way to do so is by tuning into a vast number of business and entrepreneurship podcasts scattered across the internet today.

5 Hobbies To Maximize Your Entrepreneurial Drive

5 Hobbies To Maximize Your Entrepreneurial Drive

Entrepreneurs are a special breed of person. They’re go-getters, risk-takers and dreamers. Yet, even the most driven entrepreneur needs to take a break from time to time. Spending every second of your day on your business is stressful, and you will lose your drive very soon. If you want to stay energetic and ready to take on new challenges at work, hobbies are what you need.

Making the Metaverse a Force for Good with the Metaverse Charity Foundation

Making the Metaverse a Force for Good with the Metaverse Charity Foundation

If you are a frequent reader of our website, you must have seen us mention The Sandbox, Decentraland and Axie Infinity. These are some of the most popular metaverses out there, and the one thing they all have in common is that they all have their origins in Asia. While Asia is home to all these metaverse projects, it suffers two main issues: the region has major rural-urban inequality as well as a significant wage difference between high-skilled and low-skilled occupations.

How Do Stores Get You to Spend More Money

How Do Stores Get You to Spend More Money?

Have you ever entered a grocery store to buy some milk but ended up with a bag full of items you didn’t even need? You’re not alone if you feel guilty for spending more money than you intended. It’s not our fault that we keep putting items in our shopping carts; we are manipulated to do so! To make sure you buy more, retailers will go all the way to carefully engineer every aspect of their store.